Lineage Cell Therapeutics LCTX
NYSE LCTX
$0.95 -0.02 (-1.69%)
As of: Sep 29, 2026 · 3:59 PM EDT

Lineage Cell Therapeutics (LCTX) Total Current Liabilities (2010 - 2026)

Updated

Lineage Cell Therapeutics' Total Current Liabilities was $8.02 million in Q2 2026, down 25.5% from $10.76 million a year earlier and down 1.6% from the prior quarter.

Analysis

Lineage Cell Therapeutics (LCTX) Total Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Total Current Liabilities at Lineage Cell Therapeutics came in at $11.37 million, down 18.7% from FY2024.

  • Total Current Liabilities has now declined for four consecutive years, though with a five-year compound annual growth rate of 7.9% (FY2020 to FY2025).
  • In earlier years, Total Current Liabilities was $13.98 million in FY2024 (-22.2%), $17.96 million in FY2023 (-5.4%), $18.98 million in FY2022 (-59.7%) and $47.12 million in FY2021 (+506.5%).
  • The Q2 2026 figure marks the lowest quarterly Total Current Liabilities since Q2 2021.
  • Compared with a year earlier, Total Current Liabilities has declined for 15 straight quarters, with an average decline of 25.1% over the last eight quarters.
  • The best year-over-year quarter for Total Current Liabilities over five years was Q4 2021 (growth of 506.5%); the worst was Q4 2022 (a decline of 59.7%).
  • Per Business Quant data, LCTX's Total Current Liabilities in the three quarters before Q2 2026 was $8.15 million (Q1 2026), $11.37 million (Q4 2025) and $9.38 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Lineage Cell Therapeutics 245.32 Mn 43.73 Mn - 8.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.02 Mn
Mar 31, 2026 8.15 Mn
Dec 31, 2025 11.37 Mn
Sep 30, 2025 9.38 Mn
Jun 30, 2025 10.76 Mn
Mar 31, 2025 13.09 Mn
Dec 31, 2024 13.98 Mn
Sep 30, 2024 13.86 Mn
Jun 30, 2024 15.28 Mn
Mar 31, 2024 16.89 Mn
Dec 31, 2023 17.96 Mn
Sep 30, 2023 15.88 Mn
Jun 30, 2023 16.05 Mn
Mar 31, 2023 17.23 Mn
Dec 31, 2022 18.98 Mn
Sep 30, 2022 22.74 Mn
Jun 30, 2022 25.09 Mn
Mar 31, 2022 24.59 Mn
Dec 31, 2021 47.12 Mn
Sep 30, 2021 8.79 Mn
API Access

Lineage Cell Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=LCTX&period=max&api_key=YOUR_API_KEY